Evidence map›Paper›PMID 37161785›Full record

ReviewThe EMBO journal2023

Immune synaptopathies: how maternal immune activation impacts synaptic function during development.

Michela Matteoli, Davide Pozzi, Matteo Fossati, Elisabetta Menna

Open access · bronzeAbstract readReview
In one paragraph

Review in The EMBO journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Mild SARS-CoV-2 maternal infection in mice induces transient offspring neurodevelopmental aberrance.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Michela MatteoliLaboratory of Pharmacology and Brain Pathology, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy.ORCID 0000-0002-3569-7843
Davide PozziLaboratory of Pharmacology and Brain Pathology, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy.
Matteo FossatiLaboratory of Pharmacology and Brain Pathology, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy.
Elisabetta MennaLaboratory of Pharmacology and Brain Pathology, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy.ORCID 0000-0003-2062-0154
Neuroscience Institute · ITHumanitas University · IT

Funding

European Research Council 101055323Telethon GGP19226ATelethon GGP20127Telethon GJC21044A
6 · The paper itself

Abstract

In the last two decades, the term synaptopathy has been largely used to underline the concept that impairments of synaptic structure and function are the major determinant of brain disorders, including neurodevelopmental disorders. This notion emerged from the progress made in understanding the genetic architecture of neurodevelopmental disorders, which highlighted the convergence of genetic risk factors onto molecular pathways specifically localized at the synapse. However, the multifactorial origin of these disorders also indicated the key contribution of environmental factors. It is well recognized that inflammation is a risk factor for neurodevelopmental disorders, and several immune molecules critically contribute to synaptic dysfunction. In the present review, we highlight this concept, which we define by the term "immune-synaptopathy," and we discuss recent evidence suggesting a bi-directional link between the genetic architecture of individuals and maternal activation of the immune system in modulating brain developmental trajectories in health and disease.

Indexed as

Neurodevelopmental DisordersFamilyHumansSynapsesbrain-immune system cross-talkmaternal immune activationneurodevelopmental diseasesprenatal inflammationsynapse

Identifiers

PMID37161785
PMCPMC10308362
OpenAlexW4376122008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.